
USD
+$0.00
(+0.00%
)At Close (As of Dec 12, 2025)
$6.25B
Market Cap
50.23
P/E Ratio
0.65
EPS
$48.11
52 Week High
$29.40
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $628M |
| Total Revenue | $944M |
| Cost Of Revenue | $316M |
| Costof Goods And Services Sold | $316M |
| Operating Income | $124M |
| Selling General And Administrative | $112M |
| Research And Development | $49M |
| Operating Expenses | $504M |
| Investment Income Net | - |
| Net Interest Income | -$146M |
| Interest Income | - |
| Interest Expense | $146M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $187M |
| Income Before Tax | -$23M |
| Income Tax Expense | -$3.4M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$19M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $124M |
| Ebitda | $310M |
| Net Income | -$19M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | $170M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $187M |
| Capital Expenditures | $27M |
| Change In Receivables | - |
| Change In Inventory | - |
| Profit Loss | - |
| Cashflow From Investment | -$27M |
| Cashflow From Financing | $17M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | -$844K |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$19M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $628M |
| Total Revenue | $944M |
| Cost Of Revenue | $316M |
| Costof Goods And Services Sold | $316M |
| Operating Income | $124M |
| Selling General And Administrative | $112M |
| Research And Development | $49M |
| Operating Expenses | $504M |
| Investment Income Net | - |
| Net Interest Income | -$146M |
| Interest Income | - |
| Interest Expense | $146M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $187M |
| Income Before Tax | -$23M |
| Income Tax Expense | -$3.4M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$19M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $124M |
| Ebitda | $310M |
| Net Income | -$19M |
Sector: HEALTHCARE
Industry: HEALTH INFORMATION SERVICES
Waystar Holding Corp. is a leading provider of cloud-based healthcare payment and revenue cycle management solutions, headquartered in Lehi, Utah. The company leverages innovative technology to optimize financial processes within healthcare organizations, enhancing efficiency and transparency across its versatile platform. By streamlining key functions such as patient payments, claims processing, and regulatory compliance, Waystar empowers its diverse clientele to maximize revenue performance. With a strong commitment to improving the healthcare experience for both providers and patients, Waystar is well-positioned for significant growth in the evolving healthcare landscape.